English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In this issue of Western Journal of Emergency Medicine, Moriarty et al present a thoughtfully analyzed case series of patients with crotaline snake envenomation.1 They seek to answer a common and important question: Can we define a group of pit viper victims who are at low risk for hematologic venom effects (fibrinogen degradation and/or platelet destruction) and spare these patients the time and expense of serial laboratory testing? Because their institution in Mississippi sees a large number of rattlesnake and Agkistrodon victims, Moriarty and colleagues are well positioned to address this question.

Coagulopathy: The Most Important Thing We Still Don’t Know About Snakebite